Portfolio Companies News
August 14, 2020Vicore Pharma publishes a prospectu...
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEELAND, SINGAPORE, SOUTH AFRICA, SWITZERLAND, THE UNITED KINGDOM , THE UNITED STATES OF AMERICA OR ANY OTHER JURISDICTION WHERE THE PUBLICATION, DISTRIBUTION OR RELEASE ... read more
August 12, 2020Targovax ASA: Invitation to present...
Oslo, Norway, 12 August 2020 – Targovax ASA (OSE: TRVX) will announce its second quarter and first half 2020 results on Thursday 20 August 2020. An online presentation by Targovax’s management to investors, analysts and the press will take place at 10:00am CET. The results repor... read more
August 11, 2020Fusion Pharmaceuticals Announces Se...
- Following Fusion's June 2020 initial public offering, cash runway extended into 2024 HAMILTON, ON and BOSTON, Aug. 11, 2020 /PRNewswire/ -- Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceutical... read more
August 11, 2020Aprea Therapeutics Reports Second Q...
BOSTON, Aug. 11, 2020 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE), a biopharmaceutical company focused on developing and commercializing novel cancer therapeutics that reactivate mutant tumor suppressor protein, p53, today reported financial results for the three and six months ... read more
August 10, 2020Orexo receives paragraph IV Notice ...
Uppsala, Sweden – August 10, 2020 – Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY), today announces it has received a “paragraph IV” patent certification notice from Sun Pharmaceutical Industries Limited (“Sun”). The Notice Letter advises Orexo of Sun’s filing of an Abbreviated New Drug ... read more
August 05, 2020Q2 2020 General Market Overview
Since the start in 1996, HealthCap funds have invested in 115 portfolio companies.
44 of the portfolio companies have been taken public on nine different markets.
26 of the portfolio companies’ pharmaceutical products have been approved for marketing.
Since the start in 1996, HealthCap has helped build 7 companies with a valuation of USD 1 billion or more and 35 companies with a valuation of SEK 1 billion or more.